Literature DB >> 15029228

Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo.

Z Y Chen1, C Y He, L Meuse, M A Kay.   

Abstract

We previously demonstrated that sustainable enhanced levels of transgene products could be expressed from a bacterial DNA-free expression cassette either formed from a fragmented plasmid in mouse liver or delivered as a minicircle vector. This suggested that bacterial DNA sequences played a role in episomal transgene silencing. To further understand the silencing mechanism, we systematically altered the DNA components in both the expression cassette and the bacterial backbone, and compared the gene expression profiles from mice receiving different DNA forms. In nine vectors tested, animals that received the purified expression cassette alone always expressed persistently higher levels of transgene compared to 2fDNA groups. In contrast, animals that received linearized DNA by a single cut in the bacterial backbone had similar expression profiles to that of intact plasmid groups. All three linear DNAs formed large concatemers and small circles in mouse liver, while ccDNA remained intact. In all groups, the relative amount of vector DNA in liver remained similar. Together, these results further established that the DNA silencing effect was mediated by a covalent linkage of the expression cassette and the bacteria DNA elements.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15029228     DOI: 10.1038/sj.gt.3302231

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  88 in total

Review 1.  Nanoparticles for retinal gene therapy.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2010-05-07       Impact factor: 21.198

2.  Performance of high quality minicircle DNA for in vitro and in vivo gene transfer.

Authors:  Dennis Kobelt; Martin Schleef; Marco Schmeer; Jutta Aumann; Peter M Schlag; Wolfgang Walther
Journal:  Mol Biotechnol       Date:  2013-01       Impact factor: 2.695

Review 3.  Applying horizontal gene transfer phenomena to enhance non-viral gene therapy.

Authors:  Jacob J Elmer; Matthew D Christensen; Kaushal Rege
Journal:  J Control Release       Date:  2013-08-30       Impact factor: 9.776

4.  Split AAV-Mediated Gene Therapy Restores Ureagenesis in a Murine Model of Carbamoyl Phosphate Synthetase 1 Deficiency.

Authors:  Matthew Nitzahn; Gabriella Allegri; Suhail Khoja; Brian Truong; Georgios Makris; Johannes Häberle; Gerald S Lipshutz
Journal:  Mol Ther       Date:  2020-04-17       Impact factor: 11.454

Review 5.  Plasmid engineering for controlled and sustained gene expression for nonviral gene therapy.

Authors:  Ethlinn V B van Gaal; Wim E Hennink; Daan J A Crommelin; Enrico Mastrobattista
Journal:  Pharm Res       Date:  2006-05-26       Impact factor: 4.200

Review 6.  Nanoparticle applications in ocular gene therapy.

Authors:  Xue Cai; Shannon Conley; Muna Naash
Journal:  Vision Res       Date:  2007-09-06       Impact factor: 1.886

Review 7.  Transgenesis and neuronal ablation in parasitic nematodes: revolutionary new tools to dissect host-parasite interactions.

Authors:  J B Lok; D Artis
Journal:  Parasite Immunol       Date:  2008-04       Impact factor: 2.280

Review 8.  Optimizing targeted gene delivery: chemical modification of viral vectors and synthesis of artificial virus vector systems.

Authors:  Sabine Boeckle; Ernst Wagner
Journal:  AAPS J       Date:  2006       Impact factor: 4.009

9.  The extragenic spacer length between the 5' and 3' ends of the transgene expression cassette affects transgene silencing from plasmid-based vectors.

Authors:  Jiamiao Lu; Feijie Zhang; Siqun Xu; Andrew Z Fire; Mark A Kay
Journal:  Mol Ther       Date:  2012-05-08       Impact factor: 11.454

10.  Human gamma-satellite DNA maintains open chromatin structure and protects a transgene from epigenetic silencing.

Authors:  Jung-Hyun Kim; Thomas Ebersole; Natalay Kouprina; Vladimir N Noskov; Jun-Ichirou Ohzeki; Hiroshi Masumoto; Brankica Mravinac; Beth A Sullivan; Adam Pavlicek; Sinisa Dovat; Svetlana D Pack; Yoo-Wook Kwon; Patrick T Flanagan; Dmitri Loukinov; Victor Lobanenkov; Vladimir Larionov
Journal:  Genome Res       Date:  2009-01-13       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.